Fioretti, P <br/><br/>
Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate.  [electronic resource] 

 -  Annals of the New York Academy of Sciences  1991 
 - 302-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0077-8923 
<br/><br/><label>Standard No.: </label>10.1111/j.1749-6632.1991.tb37875.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Administration, Oral<br/>Antineoplastic Agents--administration & dosage<br/>Endometrium--drug effects<br/>Estradiol--administration & dosage<br/>Female<br/>Humans<br/>Medroxyprogesterone--administration & dosage<br/>Medroxyprogesterone Acetate<br/>Middle Aged<br/>Osteoporosis--drug therapy